Incidence of and Risk Assessment for Adverse Cardiovascular Outcomes after Liver Transplantation: A Systematic Review

Monica A. Konerman, Danielle Fritze, Richard L. Weinberg, Christopher J. Sonnenday, Pratima Sharma

Research output: Contribution to journalArticlepeer-review

85 Scopus citations


Background Cardiovascular events represent a major source of morbidity and mortality after liver transplantation and will likely increase given the aging population and nonalcoholic fatty liver disease as a leading indication for transplant. The optimal cardiovascular risk stratification approach in this evolving patient population remains unclear. The aims of this systematic review are to: (1) refine the definition, (2) characterize the incidence, and (3) identify risk factors for cardiovascular events post-liver transplantation. Additionally, we evaluated performance characteristics of different cardiac testing modalities. Methods MEDLINE via PubMed, EMBASE, Web of Science, and Scopus were searched for studies published between 2002 and 2016 (model of end-stage liver disease era). Two authors independently reviewed articles to select eligible studies and performed data abstraction. Results Twenty-nine studies representing 57 493 patients from 26 unique cohorts were included. Definitions of cardiovascular outcomes were highly inconsistent. Incidence rates were widely variable: 1% to 41% for outcomes of 6 months or shorter and 0% to 31% for outcomes longer than 6 months. Multivariate analyses demonstrated that older age and history of cardiac disease were the most consistent predictors of cardiovascular events posttransplant (significant in 8/23 and 7/22, studies, respectively). Predictive capacity of various cardiac imaging modalities was also discrepant. Conclusions The true incidence of cardiovascular outcomes post-liver transplant remains unknown in large part due to lack of consensus regarding outcome definition. Overall, poor data quality and gaps in knowledge limit the ability to clearly identify predictors of outcomes, but existing data support a more aggressive risk stratification protocol for patients of advanced age and/or with preexisting cardiac disease.

Original languageEnglish (US)
Pages (from-to)1645-1657
Number of pages13
Issue number7
StatePublished - Jul 1 2017
Externally publishedYes

ASJC Scopus subject areas

  • Transplantation


Dive into the research topics of 'Incidence of and Risk Assessment for Adverse Cardiovascular Outcomes after Liver Transplantation: A Systematic Review'. Together they form a unique fingerprint.

Cite this